Cyclin-dependent kinase inhibitor 2A (CDKN2A), located on 9p21 locus, is a well-established tumor suppressor that was frequently inactivated in multiple human tumors, including melanomas, glioblastomas, pancreatic cancers, bladder cancers and the like8–10. Here, CDKN2A is linked to pancreatic neoplasm.